About Index Trending news
Analyze
Pricing

Clinical Trials

10–100 Companies
More info
Upgrade your account to download a CSV export of all the companies on this list Upgrade account

Parent markets

Medical Health Care

Submarkets

No submarkets

Sibling markets

Health and Insurance Medical Devices Pharmaceuticals Medical Professionals Hospitals Therapeutics Diagnostics

10–100 companies in Clinical Trials
Show all

Intrexon

Intrexon

Biotechnology +2
PatientPoint

PatientPoint

Fitness +2
Omicia

Omicia

Big Data +3
Cofactor Genomics

Cofactor Genomics

Biotechnology +3
AiCure

AiCure

Artificial Intelligence +2
Circle Pharma

Circle Pharma

Biotechnology +2
Chiltern

Chiltern

Clinical Trials
MedNet Solutions Inc

MedNet Solutions Inc

Software +1
CosmosID

CosmosID

Biotechnology +2
Bone Solutions Inc.

Bone Solutions Inc.

Medical +2
Popit

Popit

Personal Health +3
Phase Forward

Phase Forward

Software +1
MRN

MRN

Clinical Trials
Abreos Biosciences

Abreos Biosciences

Biotechnology +1
Intent Solutions

Intent Solutions

Clinical Trials
All companies in Clinical Trials
Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors
Companies

Growing

53
Funding and Acquisitions

2017 Q2

4 + 0
Curators of Clinical Trials
Apply
Suggest more companies
PE Hub

LabCorp to expand oncology offerings with $1.2 billion Chiltern buy: Reuters

Strategy Health
LabCorp
LabCorp
Chiltern
Chiltern
$10,680,000 Venture capital (Series A)
bizjournals , sec

http://www.bizjournals.com/stlouis/news/2017/06/28/cofactor-raises-10-7-million-from-investors.html?ana=twt

Cofactor Genomics
Cofactor Genomics
$140,000,000 Private equity
PE Hub

Medical ad firm PatientPoint raises $140 million for digital growth: Reuters

Funding
PatientPoint
PatientPoint
$3,700,000 Venture capital (Series A)
PE Hub

Lantern Pharma rallies $3.7 mln Series A

Messaging
Lantern Pharma Inc
Lantern Pharma Inc
$6,500,000 Venture capital (Series A)
PE Hub

Circle Pharma racks up about $6.5 mln

Messaging Data leaks
Circle Pharma
Circle Pharma
Acquisition
GeekWire

Seattle’s Spiral Genetics acquired by Bay-Area bioinformatics company Omicia

Science
Spiral Genetics
Spiral Genetics
Omicia
Omicia
Finextra

Chiltern railways to trial ticket-free travel

Chiltern
Chiltern
$4,500,000 Venture capital (Series A)
Added by
via FinSMEs

Circle Pharma Raises over $4.5M in Series A Funding

Circle Pharma
Circle Pharma
$16,500,000 Venture capital
FinSMEs , prnewswire

MedNet Solutions Raises $16.5m in Second Funding

Funding
MedNet Solutions Inc
MedNet Solutions Inc
Acquisition
Added by
via mna , foxwilmington , yourohiovalley

Mergers & Acquisitions - PatientPoint, acquired MedCenterDisplay

MedCenterDisplay
MedCenterDisplay
PatientPoint
PatientPoint
$1,500,000 Seed fund
Added by
via FinSMEs

Intent Solutions Raises $1.5M In Seed Funding

Intent Solutions
Intent Solutions
Finextra

Chiltern Railways to test smartphone detection payment system

Chiltern
Chiltern
Seed fund
FinSMEs

Healthcare Company Abreos Biosciences Raises Seed Funding Round

Abreos Biosciences
Abreos Biosciences
The Motley Fool

The $100 Million Platform Intrexon Investors Forgot

Intrexon
Intrexon
The Motley Fool

Why Intrexon Won't Commercialize Fuels by 2018

Intrexon
Intrexon
The Motley Fool

Better Buy: Intrexon Corporation vs. Inovio Pharmaceuticals Inc.

Intrexon
Intrexon
Inovio Pharmaceuticals
Inovio Pharmaceuticals
The Motley Fool

Intrexon Battles Thermodynamics, but Thermodynamics Always Wins

Intrexon
Intrexon
The Motley Fool

Intrexon vs. MosquitoMate: Who Has the Better Zika Tool?

Intrexon
Intrexon
$23,000,000 Venture capital (Series B)
businesswire , FinSMEs

Omicia Raises $23 Million in Series B Funding | Business Wire

Omicia
Omicia
The Motley Fool

Here's Why Intrexon Corporation Was All the Buzz in May

Health Science
Intrexon
Intrexon